Excelerate Energy initiated with a Buy at Jefferies
Jefferies initiated coverage of Excelerate Energy (EE) with a Buy rating and $39 price target The company offers a unique opportunity for exposure to long-term LNG demand tailwinds through its floating storage and regasification units, or FSRU, and regasification infrastructure that has stable contracted cash flows and minimal commodity risk, the analyst tells investors in a research note. Excelerate is capitalizing on this by growing its asset base and enhancing integration with a FSRU newbuild, LNG SPA contracts, and acquiring New Fortress Energy's Jamaican LNG-to-power assets, the firm added.
Confident Investing Starts Here:
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Post
an hour ago
- New York Post
Mayor quits after facing harassment, threats as texts show her calling Buc-ee's project opponents ‘terrorists'
The former mayor of Palmer Lake, Colorado, called people who were against land annexation for a Buc-ee's store and other measures 'terrorists' and 'losers,' according to local media reports and text messages included in a lawsuit. Glant Havenar, who resigned from serving as the town's mayor mid-week, used the insults when talking about people opposed to the project in text exchanges with a friend, 9News reported Thursday, citing court documents. Advertisement Integrity Matters and other entities included the messages in a recent court filing for a lawsuit against the town in connection to the Buc-ee's, according to the outlet and KRDO13. Before that, they had been shared in a Signal group chat by Havenar's former friend. The filing containing the messages alleged that Havenar tried to sway public opinion by setting up social media accounts under different names to engage with people online, according to 9News. She is also facing accusations from Integrity Matters that she violated regulations about open meetings and talked about executive sessions inappropriately, with the non-profit pointing to messages as purported evidence of that, the outlet reported. Advertisement 4 Palmer Lake Mayor Glant Havenar resigned from her post after allegedly insulting opponents of a proposed Buc-ees in the area. NEXT 9News/YouTube 4 Interstate 25 near Palmer Lake connects Denver and Colorado Springs. NEXT 9News/YouTube Contentions about the Buc-ee's have been brewing in the area for quite some time. An effort to recall a few members of the town's board of trustees was launched earlier in the year related to how a meeting late last year about the Buc-ee's annexation was handled, according to local reports. Advertisement Havenar told KRDO13 that harassment she has been experiencing from others in connection to the Buc-ee's annexation played a major role in her decision to resign. 4 A placard raising concerns about the Buc-ees location that could cause problems to the local environment. NEXT 9News/YouTube She also wanted to stave off additional conflict in the community that could arise if opponents pursued a recall of her as mayor, according to the outlet. 'I didn't want petitioners outside all summer long trying to get signatures for me with their posters and their banners and their signs disrupting the peace of Palmer Lake,' Havenar said. Advertisement Asked about the text messages, she said she had been 'harassed for 10 months' and said 'there's not anybody on this planet that's not going to say unkind things about people that are harassing them,' according to the outlet. 4 A Buc-ees convenience store in Daytona Beach, Florida on Dec. 29, 2022. MelissaMN – She said that releasing private text messages 'was not the right thing to do' and that 'not all of them were true.' FOX Business reached out to Town Administrator Dawn Collins and the Palmer Lake town office. The site where the Buc-ee's could potentially go in the area is located near Interstate 25, according to 9News. Buc-ee's had over 50 locations across the country as of late May.
Bloomberg
2 hours ago
- Bloomberg
Taiwan Official Discusses US Energy Cooperation at Alaska Summit
Taiwan's top presidential aide discussed energy cooperation with US officials at a summit this week in Alaska, where a liquefied natural gas project has come into focus for potential exporting to the island. Pan Men-an, secretary-general to Taiwan's president, gave a speech at the summit, which was held from June 2-5 and also attended by vice economic minister Lai Chien-hsin and CPC Corp. Chairman Fang Jeng-zen.
Yahoo
3 hours ago
- Yahoo
Jefferies Maintains Buy Rating on Rhythm Pharmaceuticals (RYTM), Sets $80 Price Target
In a report released on June 4, Dennis Ding from Jefferies maintained a Buy rating on Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) with a price target of $80.00. The analyst based the rating on the company's strategic developments and promising pipeline. One of the primary reasons behind the rating was the anticipated Phase II data for the oral treatment for hypothalamic obesity (HO). It is expected to deliver notable BMI reduction and has been de-risked, thereby extending the potential of the franchise beyond the current expiration dates. A scientist conducting research in a laboratory, studying a Petri dish with advanced biopharmaceuticals. The analyst stated that management is confident in the weekly subcutaneous (subQ) treatment, which closely aligns with the previously approved setmelanotide, and thus further adds to the positive outlook for Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM). According to Ding, the setmelanotide Phase II open-label trial for Prader-Willi Syndrome can also pave the way for a significant opportunity if successful, even after its previous challenges. Management is focusing on patient starts instead of the immediate revenue post-launch, and this strategy supports the long-term growth prospects, according to the analyst. Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM) is a commercial-stage biopharmaceutical company that develops and commercializes therapeutics for the treatment of rare diseases. Its product pipeline includes IMCIVREE (setmelanotide), a precision medicine that treats hyperphagia and severe obesity caused by rare melanocortin-4 receptor (MC4R) diseases. The company also has other programs, including a preclinical suite of investigational candidates to treat congenital hyperinsulinism and a clinical development program for setmelanotide in other rare MC4R pathway diseases. While we acknowledge the potential of RYTM as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None.
